Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Neurochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 7561891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.

  1995cited by this paper
• Amyloid beta-peptide spin trapping. I: Peptide enzyme toxicity is related to free radical spin trap reactivity.

  1995cited by this paper
• Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates.

  1995cited by this paper
• Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels.

  1994cited by this paper
• beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

  1994cited by this paper
• Effects of Alzheimer's disease-related beta amyloid protein fragments on enzymes metabolizing phosphoinositides in brain.

  1994cited by this paper
• A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

  1994cited by this paper
• Alzheimer's Disease: A Central Role for Amyloid

  1994cited by this paper
• Amyloid beta peptides act directly on single neurons.

  1993cited by this paper
• β‐Amyloid Neurotoxicity in Human Cortical Culture Is Not Mediated by Excitotoxins

  1993cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker.

  1992cited by this paper
• beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology.

  1992cited by this paper
• The Alzheimer amyloid precursor is associated with the detergent- insoluble cytoskeleton

  1991cited by this paper
• Action of amyloid beta-protein on protein kinase C activity.

  1991cited by this paper
• Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

  1991cited by this paper
• Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain.

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Isolated hippocampal neurons in cryopreserved long‐term cultures: Development of neuroarchitecture and sensitivity to NMDA

  1988cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP.

  1978cited by this paper

• NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies

  2025cites this paper
• Exploring the therapeutic efficacy of Chlorella pyrenoidosa peptides in ameliorating Alzheimer's disease

  2023cites this paper
• The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression

  2023cites this paper
• The amyloid state of proteins: A boon or bane?

  2022cites this paper
• Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease

  2021cites this paper
• Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

  2019cites this paper
• Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases

  2019cites this paper
• Current updates on the regulation of beta-secretase movement as a potential restorative focus for management of Alzheimer's disease.

  2019cites this paper
• Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

  2018cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease

  2015cites this paper
• Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer’s Disease Pathogenesis

  2015cites this paper
• The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

  2014cites this paper
• Hippocampus and nitric oxide.

  2014cites this paper
• Oxidative and Nitrosative Modifications of Biliverdin Reductase-A in the Brain of Subjects with Alzheimer's Disease and Amnestic Mild Cognitive Impairment

  2011cites this paper
• Role of Glutamine in Neuronal Survival and Death During Brain Ischemia and Hypoglycemia

  2011cites this paper
• Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.

  2011cites this paper
• Serum Glutamine Synthetase Has No Value as a Diagnostic Biomarker for Alzheimer’s Disease

  2011cites this paper
• Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics

  2006cites this paper
• Selective Cu2+/Ascorbate‐Dependent Oxidation of Alzheimer's Disease β‐Amyloid Peptides

  2004cites this paper
• Elevation of mitochondrial glutathione by γ‐glutamylcysteine ethyl ester protects mitochondria against peroxynitrite‐induced oxidative stress

  2003cites this paper
• The Glutamatergic System and Alzheimer’s Disease

  2003cites this paper
• CU(II)-catalyzed oxidation of Alzheimer's disease beta-amyloid peptide and related sequences: remarkably different selectivities of neurotoxic betaAP1-40 and non-toxic betaAP40-1.

  2003cites this paper
• Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences.

  2003cites this paper
• Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

  2002cites this paper
• Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer ’ s amyloid-peptide 1 – 42

  2002cites this paper
• Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.

  2001cites this paper
• Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.

  2000cites this paper
• Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.

  2000cites this paper
• Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.

  2000cites this paper
• The Antioxidant Vitamin E Modulates Amyloid β-Peptide-Induced Creatine Kinase Activity Inhibition and Increased Protein Oxidation: Implications for the Free Radical Hypothesis of Alzheimer's Disease

  1999cites this paper
• Amyloid beta-peptide inhibits Na+-dependent glutamate uptake.

  1999cites this paper
• Why tryptophan hydroxylase is difficult to purify: a reactive oxygen-derived species-mediated phenomenon that may be implicated in human pathology.

  1998cites this paper
• Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.

  1998cites this paper
• Oxidatively Induced Structural Alteration of Glutamine Synthetase Assessed by Analysis of Spin Label Incorporation Kinetics: Relevance to Alzheimer's Disease

  1997cites this paper
• beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  1997cites this paper
• Oxidative modification of glutamine synthetase by amyloid beta peptide.

  1997cites this paper
• Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation.

  1996cites this paper
• Separation and analysis of peptides and proteins.

  1993cites this paper